SCHEMBL10301924

SCHEMBL10301924

COc1ccc(-c2ccc(CCc3ccc(CO)c(F)c3F)cc2)c(F)c1F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDCD1 Q15116 1/20 0.38
CD274 Q9NZQ7 1/20 0.38
FFAR4 Q5NUL3 1/20 0.37
CHKA P35790 1/20 0.36
CYP19A1 P11511 2/20 0.35
PDE5A O76074 1/20 0.35
PDE4A P27815 1/20 0.35
PDE1A P54750 1/20 0.35
PDE1B Q01064 1/20 0.35
PDE4B Q07343 1/20 0.35
PDE4C Q08493 1/20 0.35
PDE4D Q08499 1/20 0.35
PDE3B Q13370 1/20 0.35
PDE1C Q14123 1/20 0.35
PDE3A Q14432 1/20 0.35
ALOX5 P09917 1/20 0.35
GABRA1 P14867 1/20 0.35
GABRB2 P47870 1/20 0.35
FYN P06241 1/20 0.34
ABCB1 P08183 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12735563 0.95 FYN (0.39) PDCD1CD274FFAR4CHKACYP19A1
SCHEMBL12740101 0.95 FYN (0.39) PDCD1CD274FFAR4CHKACYP19A1
SCHEMBL10303017 0.94 CYP19A1 (0.39) FFAR4CHKACYP19A1ALOX5GABRA1
SCHEMBL12821150 0.89 TUBB4A (0.43) FFAR4CYP19A1ALOX5ABCB1KDM4E
SCHEMBL12719232 0.89 TUBB4A (0.43) FFAR4CYP19A1ALOX5ABCB1KDM4E
SCHEMBL10301917 0.89 FFAR4 (0.37) FFAR4CHKACYP19A1ALOX5GABRA1
SCHEMBL12740086 0.89 CHKA (0.36) FFAR4CHKACYP19A1ALOX5GABRA1
SCHEMBL12735539 0.89 CHKA (0.36) FFAR4CHKACYP19A1ALOX5GABRA1
SCHEMBL10302996 0.88 CALM1 (0.41) FFAR4CHKACYP19A1ALOX5GABRA1
SCHEMBL10301925 0.88 FFAR4 (0.39) FFAR4CHKAGABRA1GABRB2S1PR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8216489-B2 Three-ring liquid crystal compound having lateral fluorine, liquid crystal composition, and liquid crystal display device JNC CORPORATION (JP) 2012-07-10 US disclosed
US-20110037024-A1 THREE-RING LIQUID CRYSTAL COMPOUND HAVING LATERAL FLUORINE, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE CHISSO CORPORATION (JP) 2011-02-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110037024-A1 THREE-RING LIQUID CRYSTAL COMPOUND HAVING LATERAL FLUORINE, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE LEF1, LAS1L, L3MBTL3 PDCD1 1107/4885CD274 573/4885FFAR4 1669/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.